Dr RR Baliga's "Got Knowledge Doc" Podkast

🚀 Exciting breakthroughs in metabolic medicine! 💊 This August 2025 Nature Reviews Drug Discovery review by Dr. Daniel Drucker dives deep into the evolution of GLP-1-based therapies—covering semaglutide, tirzepatide, multi-agonists, oral small molecules, and their growing impact beyond diabetes into obesity, liver disease, and neurodegeneration. 🧠⚖️💥 📉 From gut hormones to global health, GLP-1...

🚨 New insights from the European Heart Journal! 🫀✨ This study shows that where you store fat — not just how much — matters for how your heart and arteries age .   📌 Android fat (belly) = faster cardiovascular aging 📌 Gynoid fat (hips/thighs) = protective, especially in women 🧬 Using MRI (ShMOLLI), metabolomics & AI (CatBoost), researchers predicted cardiovascular age from fat patterns.   💡...

👨‍⚕️🔬 Just explored the latest JAMA review on Prostatitis —a masterclass in clarity and clinical relevance! From LUTS to CP/CPPS, it unpacks the full spectrum: 🧪 Meares-Stamey testing, 📊 NIH-CPSI scoring, and 🚀 modern management strategies. A must-read for anyone navigating the nuanced world of male pelvic health. #Urology #MensHealth #Prostatitis #PrecisionMedicine 🧠📘

🚨 New in JACC (Aug 2025): Evidentiary Landscape of HF Therapies 🫀   Over the last decade, the heart failure field has shifted from the "mortality reduction era" (ACEIs, β-blockers, MRAs) ➡️ to the "hospitalization reduction era" (SGLT2i, ARNI in HFpEF, iron therapy).   🔑 Key Insights: ⚖️ FDA decisions reflect both rigor and flexibility — approving sacubitril/valsartan in HFpEF despite a missed...

🧬 Mesenchymal Drift: A New Hallmark of Aging & Disease 🧬   Researchers uncover that Mesenchymal Drift (MD) —the widespread activation of mesenchymal genes across tissues—is a conserved feature of aging and multiple diseases .   📉 High MD = worse outcomes (e.g., in Idiopathic Pulmonary Fibrosis, survival dropped from 1,027 to 294 days). 🔄 Excitingly, partial reprogramming with Yamanaka factors...

🚨 New insights on atrial fibrillation (AF) treatment!   A major meta-analysis in Annals of Internal Medicine 🧠📊 confirms that catheter ablation reduces stroke 🧨, heart failure hospitalizations 🏥, and mortality ⚰️—especially in patients with HF.   While surgical ablation with LAA occlusion shows benefit in stroke prevention, catheter-based strategies 💉🔥 continue to lead in outcomes and safet...

🚨 New insights from Annals of Internal Medicine challenge long-held beliefs about alcohol 🍷 and health 🧬. A 2025 U.S. Surgeon General advisory links even modest drinking to increased cancer risk 🎗️—especially breast and oral cancers. Experts now urge clearer labeling, better patient counseling 🩺, and culturally normalizing abstinence 🌱. Is it time to rethink the "glass of red wine" advice? 🧐...

💡 Renal Denervation: A New Era in Hypertension Care 🩺   Despite decades of effective medications, only ~25% of patients worldwide achieve blood pressure control. Non-adherence remains a huge barrier. 📉   This Nature Reviews Cardiology article (Fisher & Kirtane, Sept 2025) explores the journey of renal denervation (RDN) — from Smithwick's sympathectomy in the 1950s to today's FDA-approved radiof...

📘 New Insights on Diverticulitis 📊🔬💊 Did you know that while  1–4% of people with diverticulosis develop diverticulitis, it still accounts for ~200,000 hospitalizations annually in the US and >$6.3B in healthcare costs? 🚑💰 ✅ CT scan remains the gold standard for diagnosis 🖼️ ✅ Observation & pain control are first-line for uncomplicated cases 💊 ✅ Antibiotics reserved for high-risk groups...

🚨 Hypertension remains the world's #1 killer — yet fewer than 1 in 4 patients achieve control.   💊 Exciting innovations are reshaping the field: ✔️ Aprocitentan (endothelin receptor antagonist) – first new class in decades ✔️ siRNA (zilebesiran) – 6-monthly dosing, tackling adherence ✔️ Aldosterone synthase inhibitors – overcoming "aldosterone escape" ✔️ Non-steroidal MRAs & neprilysin inhibitor...

🌟 Ramanuja (1017–1137 CE), one of India's greatest theologians, shaped Vishishtadvaita Vedanta (Qualified Non-Dualism). His vision of Atman (self) and Brahman (supreme reality) , united through bhakti (devotion) , transformed Hindu theology and inspired generations. 🕉️📖   💡 His commentaries on the Upanishads, Bhagavad Gita, and Brahma Sutras laid the foundation of Sri Vaishnavism and emphasized...

🧬 South Asians make up 25% of the world—yet just 3% of major cardiovascular trials. A new systematic review (310 RCTs, 1M+ participants) reveals stark underrepresentation, especially outside India. No South Asians in trials for heart failure, cardiac arrest, or valvular disease. 📉 The data gap is real—and it's limiting care.   🔍 We need global trial designs that are inclusive, disaggregated, an...

🚶‍♀️📲 New research alert! A massive natural experiment tracking 7,447 relocations across 1,609 US cities reveals that urban walkability directly boosts physical activity 🏙️💪   📈 Moving to more walkable cities increased daily steps by ~1,100 and doubled compliance with MVPA guidelines! 🎯 A powerful case for urban design as preventive medicine.   🔗 A must-read for public health advocates, city...

🧂 Salt sensitivity of blood pressure (SSBP) is an independent risk factor for CVD.   🚹🚺 Women are more salt-sensitive than men, especially after menopause. ⚙️ Key drivers: RAAS, ENaC, natriuresis, and immune pathways. 💉 Estrogen protects, testosterone raises pressure, menopause tips the balance.   🐀 From Dahl's rats to Conn's syndrome, SSBP research shows why sex-specific, personalized therap...

Liver, Lipids, and the Left Ventricle 🩸🫀🧬   The NEJM review reminds us that fatty liver isn't just a liver problem . MASLD drives risk for heart disease, diabetes, kidney dysfunction, and even cancers . 🚨   Cardiovascular disease remains the leading cause of death in MASLD—outpacing cirrhosis and cancer. 🫀💔   With new tools like FIB-4, VCTE, ELF , and promising drugs such as resmetirom and G...

🧓💊 The COMBINE-AF substudy offers important guidance for managing frail, elderly, VKA-experienced patients with atrial fibrillation. Switching to standard-dose DOACs reduced stroke/systemic embolism risk and cut intracranial & fatal bleeding 🧠🛡️, but raised gastrointestinal bleeding rates 🍽️🩸—especially with certain agents. Sensitivity analyses show apixaban & edoxaban may offer a safer bleedi...

🧠 Meet the Northwestern SuperAgers —individuals 80+ with memory scores rivaling those decades younger! 📚 They show  thicker cortices , more von Economo neurons , fewer neurofibrillary tangles , and remarkable social engagement . 🏆 Their brains offer clues to resisting age-related decline—reshaping how we view aging potential. ✨ #SuperAgers #HealthyLongevity #BrainHealth

🚨 Hot off the press! The 2025 ACC/AHA High Blood Pressure Guidelines are here 🩺📊 — bringing sharper strategies to detect, treat & prevent hypertension. From HBPM 🏠 to PREVENT risk scoring 🎯 and protecting against end-organ damage 🫀🧠 , these updates empower clinicians & patients alike. Measure it. Manage it. Maintain it. 💪🌟 #Hypertension #Cardiology #Guidelines

🌳 Trees aren't just trees – they're bustling holobionts 🌱🧫! New Nature research reveals that living wood hosts vast, specialized microbiomes, with heartwood and sapwood fostering distinct microbial worlds.   These microbes shape carbon & nitrogen cycling 🌍, influence tree health 🌳💪, and reflect deep host–microbe coevolution 🧬. Rethinking forests as holobionts could transform conservation, c...

💙 Heart failure prevention is a lifelong journey – from identifying those at risk 🩺, to managing pre-HF 🚦, to optimizing care in advanced stages 🫀. This joint HFSA & ASPC statement bridges primary, secondary & tertiary prevention , targeting traditional risks (HTN, diabetes, obesity) ⚠️, non-traditional risks (genetics, SDOH) 🌍, and leveraging tools like biomarkers 🔬, cardiac rehab 🏃, and h...

🦠 Your gut is home to trillions of microbes shaping digestion, immunity, and even mood! 🌿 This new study of 150 adults over 12 weeks found 📈 higher alpha diversity ( p =0.003) and clear shifts in microbiome composition, with Faecalibacterium ↑ and Bacteroides ↓. Such changes could boost metabolic and immune health—but more research is needed for long-term insights. 💡 Nurture your inner ecosyst...

🚀 Breaking News in Cardio-Oncology! 🫀🎗️   A new randomized trial in European Journal of Heart Failure shows that low-dose sacubitril/valsartan (an angiotensin receptor–neprilysin inhibitor) given before adjuvant therapy in early breast cancer patients completely prevented cancer therapy-related cardiac dysfunction (CTRCD) over 12 months — 0% vs 26.3% in standard care (p=0.006, NNT=3.8).   💡 Why...

🧬 Geroscience is redefining how we think about aging — shifting focus from treating one disease at a time to targeting the biological processes that drive all age-related conditions.   From 🍽️ caloric restriction and 💊 metformin , to 🛡️ rapalogs and 🔍 senolytics , the evidence is mounting: intervening in aging biology may improve healthspan, resilience, and quality of life.   📊 The latest JAMA...

🚨 New Insights in HFpEF Therapy! 🫀🔬   A groundbreaking JACC: Basic to Translational Science study shows that hydrogen sulfide (H₂S) deficiency is not just a byproduct—but a central driver of cardiometabolic heart failure with preserved ejection fraction (HFpEF) .   Using human plasma analysis + two robust preclinical models, researchers found: ⚠️ ~80–90% reduction in circulating H₂S 💔 Diastoli...

🌟 Al-Ghazali (1058–1111 CE) – The "Proof of Islam" 🌟   A Shafi'i jurist, Ash'arite theologian, Sufi mystic, and philosopher, Al-Ghazali transformed Islamic thought by uniting orthodox theology with spiritual depth . 📜✨   From his Tahafut al-Falasifa 🧠🔥 (Incoherence of the Philosophers) challenging Aristotelian science, to his Ihya Ulum al-Din 📖💫 reviving the heart of the Islamic faith, he...